Harry Haverkos, MD

Harry Haverkos, MD

Name: Harry Haverkos, MD

Department of Primary Appointment: Preventive Medicine & Biostatistics
Title: Associate Professor

Email: harry.haverkos@usuhs.edu (link sends e-mail)
Office Phone: (301) 295-3704
Room: Bldg A, Room 1039G



Harry W. Haverkos, MD, Captain (retired) U.S. Public Health Service. Dr. Haverkos is an infectious diseases physician and epidemiologist. He joined the USPHS in 1981 as an Epidemic Intelligence Officer (EIS) at the Centers for Disease Control and Prevention in Atlanta. At CDC he initiated national surveillance for AIDS and participated in epidemiologic studies among homosexual men, Caribbean natives, hemophiliacs and blood transfusion recipients. In 1984 he transferred to the National Institutes of Health in Bethesda and served as a medical officer at the National Institute of Allergy and Infectious Diseases (NIAID) and as a branch chief; AIDS coordinator; Acting Director, Division of Clinical Research; and intramural physician-scientist at the National Institute on Drug Abuse (NIDA). For seventeen years (1989-2006) he served in the Infectious Disease Service, Department of Medicine at Walter Reed Army Medical Center as a physician and educator. In 1998 he transferred to the Food and Drug Administration as a Medical Reviewer in the Division of Antiviral Drug Products, Center for Drug Evaluation and Research. Harry retired in August 2006; and served as a Special Volunteer in the Viral Epidemiology Branch at the National Cancer Institute form 2006-2009. He is currently an Associate Professor, Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences in Bethesda, Maryland.


  • B.S. Pre-professional Studies (Science Major) University of Notre Dame, Indiana
  • M.D. Medical College of Ohio at Toledo

Areas of Expertise

  • Internal Medicine
  • Infectious Diseases
  • Epidemiology

Research Interest

  • Infectious determinant of chronic diseases
  • Active surveillance for diabetes, multiple sclerosis, and schizophrenia
  • Polycyclic aromatic hydrocarbons and cervical cancer

Selected Recent Publications

Bennett C, Kuhn AE, Haverkos HW. Human papillomavirus and tar hypothesis for squamous cell cervical cancer J Bioscience 2010; 35:331-7

Haverkos HW. Book Review: Outbreak Investigations around the World, edited by Mark S. Dworkin. Emerg Infect Dis 2009; 15:1882.

Greenburg D, Haverkos H, Vigersky R. Diabetes mellitus, active components, U.S. Armed Forces. Medical Surveillance Monthly Report. February 2009; 16 (2): 7-9.

Haverkos HW. Multifactorial etiology of Kaposi's sarcoma: a hypothesis. J Bioscience 2008; 33:643-651.

Haverkos HW. Multifactorial etiology of cervical cancer: a hypothesis. Medscape General Medicine 2005; 7(4):56.

Haverkos HW. Viruses, Chemicals and Co-carcinogenesis. Oncogene 2004; 23:6492-99.

Haverkos HW, Soon G, Steckley SL, Pickworth WB. Cigarette smoking and cervical cancer: Part 1: a meta analysis. Biomed Pharmacother 2003; 57:67-77.

Steckley SL, Pickworth WB, Haverkos HW. Cigarette smoking and cervical cancer; Part 2: a geographic variability study. Biomed Pharmacother 2003; 57:78-83.

Haverkos HW, Battula N, Drotman DP, Rennert O. Enteroviruses and type 1 diabetes mellitus. Biomed Pharmacother 2003; 57:379-385.